Dr. Kebbekus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 E 3rd St
# Essentia
Duluth, MN 55805Phone+1 218-786-8364
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2008 - 2011
University of Minnesota Medical SchoolClass of 2008
Certifications & Licensure
NH State Medical License 2011 - Present
MN State Medical License 2013 - 2025
WI State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsA phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancerKonstantin H. Dragnev, Jeremy D. Whyman, Cynthia K. Hahn, Peter E. Kebbekus, Sarah F. Kokko
Journal of Thoracic Disease. 2018-09-01 - 107 citationsThe Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B CellsJ. Claire Godbersen, Leigh Ann Humphries, Olga V. Danilova, Peter E. Kebbekus, Jennifer R. Brown
Clinical Cancer Research. 2014-03-15 - 90 citationsPersistence Length of RNAPeter Kebbekus, David E. Draper, Paul J. Hagerman
Biochemistry. 1995-04-04
Press Mentions
Clinical Trial Roadblocks: Patients, Families Anguish over Being Denied Participation in Cutting-Edge StudiesMarch 20th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
